Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), today provides an update on the comprehensive test and research program of its subsidiary Philips Respironics to assess potential ...
NEW YORK — The Food and Drug Administration says 561 deaths have been reported in connection to recalled Philips devices to treat obstructive sleep apnea and other breathing disorders. The FDA said ...
Shares of medical giant Philips surged Monday after the company announced that it paid over a billion dollars to settle personal injury claims tied to its recalled sleep apnea devices. Philips ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback